Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 5,492 | 3,205 | 707 | 23 | 96 |
| Gross Profit | 5,492 | 3,205 | 707 | 23 | 96 |
| Operating Expenses | 8,587 | 7,190 | 5,330 | 4,250 | 4,161 |
| Operating Income | -3,095 | -3,985 | -4,623 | -4,227 | -4,065 |
| Other Income | 186 | 119 | 83 | 88 | 110 |
| Pre-tax Income | -2,909 | -3,866 | -4,540 | -4,139 | -3,955 |
| Net Income Continuous | -2,909 | -3,866 | -4,540 | -4,139 | -3,955 |
| Net Income | $-2,909 | $-3,866 | $-4,540 | $-4,139 | $-3,955 |
| EPS Basic Total Ops | -1.20 | -3.60 | -28.30 | -23.00 | -22.30 |
| EPS Basic Continuous Ops | -1.18 | -3.56 | -24.84 | -22.96 | -22.27 |
| EPS Diluted Total Ops | -1.20 | -3.60 | -28.30 | -23.00 | -22.30 |
| EPS Diluted Continuous Ops | -1.18 | -3.56 | -24.84 | -22.96 | -22.27 |
| EBITDA(a) | $-2,978 | $-3,812 | $-4,412 | $-3,955 | $-3,744 |